The following abstracts represent the presentations given at IWWM-10 (NYC-2018), Session 9: Clinical Trials Updates in WM: Ibrutinib
Session Chair: Lia Palomba (USA)
Ibrutinib monotherapy in treatment-naïve WM patients S. Treon (USA)
Long term follow-up of ibrutinib monotherapy in previously-treated WM patients: Update of pivotal trial R. Advani (USA)
Ibrutinib monotherapy in rituximab-refractory WM patients J. Trotman (Australia)
Randomized study of ibrutinib/rituximab versus rituximab in symptomatic WM patients M. Dimopoulos (Greece)